IPO
Went public as Hillstream BioPharma Inc. Priced at US$4.00 a share on Jan 11, 2022.
- Price
- US$4.00 a share
- Shares offered
- 3,750,000 shares of common stock
- Offering size
- US$15 million
- Underwriters' option
- Up to 562,500 more shares
- Listing
- HILS on the Nasdaq Capital Market
- Underwriter
- ThinkEquity
- Shares delivered
- On or about Jan 14, 2022
Steps
| Step | When |
|---|
| Draft sent to the SEC in confidence | May 17, 2021 |
|---|
| Filed publicly | Sep 27, 2021 |
|---|
| Amended 4 times | Newest Jan 5, 2022 |
|---|
| Shares registered with an exchange | Jan 10, 2022 |
|---|
| Declared effective by the SEC | Jan 11, 2022 |
|---|
| Final prospectus, with the price | Jan 13, 2022 |
|---|
Filings
| Filing | Filed |
|---|
| 424B4 · Prospectus | Jan 13, 2022 |
|---|
| EFFECT · Notice that a registration is effective | Jan 11, 2022 |
|---|
| CERT · Exchange's certificate of listing | Jan 11, 2022 |
|---|
| 8-A12B · Registration of shares for listing on an exchange | Jan 10, 2022 |
|---|
| CORRESP · Letter to the SEC | Jan 7, 2022 |
|---|
| CORRESP · Letter to the SEC | Jan 7, 2022 |
|---|
| S-1/A · Registration statement, amended | Jan 5, 2022 |
|---|
| S-1/A · Registration statement, amended | Jan 3, 2022 |
|---|
| FWP · Free writing prospectus | Dec 20, 2021 |
|---|
| S-1/A · Registration statement, amended | Dec 10, 2021 |
|---|
| CORRESP · Letter to the SEC | Oct 15, 2021 |
|---|
| S-1/A · Registration statement, amended | Oct 15, 2021 |
|---|
| UPLOAD · Letter from the SEC | Oct 7, 2021 |
|---|
| CORRESP · Letter to the SEC | Sep 27, 2021 |
|---|
| S-1 · Registration statement | Sep 27, 2021 |
|---|
| UPLOAD · Letter from the SEC | Aug 23, 2021 |
|---|
| DRS/A · Draft registration statement, amended | Aug 4, 2021 |
|---|
| DRSLTR · Letter to the SEC with a draft | Aug 3, 2021 |
|---|
| UPLOAD · Letter from the SEC | Jul 19, 2021 |
|---|
| DRS/A · Draft registration statement, amended | Jun 21, 2021 |
|---|
| DRSLTR · Letter to the SEC with a draft | May 17, 2021 |
|---|
| DRS · Draft registration statement | May 17, 2021 |
|---|
From the cover of the final prospectus (424B4) filed Jan 13, 2022